Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9ED8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,128
Award facts
- Contract value 100% obligated
- $23,128.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $23,128.02. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company maintains an extensive portfolio of pharmaceutical products and medical supplies delivered under federal contracts, including brand-name medications, generics, vaccines, and specialized medical commodities across multiple therapeutic domains. This contract reflects AmerisourceBergen's established capability to fulfill pharmaceutical supply requirements through open competition and its role as a primary vendor within the DLA's medical supply chain infrastructure supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9ED8?
SPE2DR26F9ED8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F9ED8 worth?
The government has obligated $23,128 on SPE2DR26F9ED8.
Is contract SPE2DR26F9ED8 an order under another contract?
Yes. SPE2DR26F9ED8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9ED8 competed?
The extent of competition for SPE2DR26F9ED8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award